Delivery Order SPE2DB20D3103-SPE2DB25FM7E8
Award Date
2/14/25
Potential Completion Date
2/18/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FN3W8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,023.12 firm fixed-price delivery order is for the supply of 4,564,235,461 units of the medication Cyclophosphamide 2 GM Vials. The contract has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $8,730.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,557,853,913 units of the drug Cyclophosphamide 2 GM Vials. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,393.01 firm fixed-price delivery order is for the supply of 4566893778 CYCLOPHOSPHAMIDE 500 MG VIALS. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,746.50 Firm Fixed Price Delivery Order covers the supply of 4566111213 - Cyclophosphamide 2 GM Vials, with a period of performance through October 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Cyclophosphamide 2 gm/10 mL vials, a critical pharmaceutical product. The contract, valued at $4,906.40, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). This contract is a Delivery Order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,134.58, is for the delivery of 4,564,661,962 units of the drug Cyclophosphamide 2 GM Vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a period of performance ending on May 21, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to supply Cyclophosphamide 2 GM Vials. The contract is a Delivery Order with a Firm Fixed Price, valued at $20,478.02, and has an Ultimate Completion Date of June 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Cyclophosphamide 2 GM vials. The $14,682.20 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a performance period through November 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
The federal contract award SPE2DB20D3103 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,545.80 firm fixed-price delivery order is for the supply of 4,557,046,174 units of the drug Cyclophosphamide 2 GM Vials. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award is for the delivery of Cyclophosphamide 2 GM vials to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 29, 2024 with a ceiling value of $27,616.43. This is a firm-fixed price delivery order contract with an ultimate completion date of April 30, 2024. The contract is not set aside for any small business program. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...